XML 44 R14.htm IDEA: XBRL DOCUMENT v2.4.0.8
Shareholders' Equity (Deficit)
6 Months Ended
Apr. 30, 2014
Equity [Abstract]  
Shareholders' Equity (Deficit)
Shareholders’ Equity (Deficit)
Changes in shareholders’ equity (deficit)
Changes in shareholders’ equity (deficit) were as follows for the six months ended April 30, 2014:
 
 
Total
Shareholders’
Equity (Deficit)
 
Noncontrolling
interest
 
Total
Equity (Deficit)
Balance at October 31, 2013
$
(12,412
)
 
$
(780
)
 
$
(13,192
)
Common stock issued for convertible note conversions
32,421

 

 
32,421

Common stock issued to settle make-whole obligation
12,639

 

 
12,639

Share-based compensation
1,327

 

 
1,327

Sale of common stock, net of registration fees
37,231

 

 
37,231

Taxes paid upon vesting of restricted stock awards, net of stock issued under benefit plans
(1,111
)
 

 
(1,111
)
Preferred dividends – Series B
(1,600
)
 

 
(1,600
)
Other comprehensive loss - foreign currency translation adjustments
110

 

 
110

Net loss
(26,447
)
 
(407
)
 
(26,854
)
Balance at April 30, 2014
$
42,158

 
$
(1,187
)
 
$
40,971



Common Stock Issuances
During the six months ended April 30, 2014, certain investors elected to convert a total of $37.0 million principal of $38.0 million in aggregate principal of the 8.0% Senior Unsecured Convertible Notes. As a result of these conversions, the Company issued 23,870,979 shares of common stock related to the conversions, 5,399,747 shares to settle the make-whole obligation and 247,553 shares for accrued interest.
On January 23, 2014, the Company completed a public offering of 25.3 million shares of common stock, including 3.3 million shares sold pursuant to the full exercise of an over-allotment option granted to the underwriters. All shares were offered by the Company at a price of $1.25 per share. Total net proceeds to the Company were approximately $29.5 million.
The Company may sell common stock on the open market from time to time. The proceeds of these sales may be used to pay obligations related to the Company's outstanding Series I and Series B preferred shares and the 8.0% Senior Unsecured Convertible Notes or for general corporate purposes. During the six months ended April 30, 2014, the Company sold 4,387,600 shares of the Company's common stock at prevailing market prices through periodic trades on the open market and raised approximately $7.7 million, net of fees.



Warrant Issuance
On September 4, 2013, the Company entered into a co-marketing agreement with NRG Energy ("NRG") for the marketing and sales of the Company's power plants. The terms of the agreement included the issuance of warrants to NRG that permit NRG to purchase up to 5.0 million shares of the Company's common stock at predetermined prices based on attaining minimum sales goals. The first tranche of 1.25 million warrants expired unvested on March 1, 2014. There are two tranches remaining of warrants with varying strike prices, varying minimum levels of qualifying orders, and different vesting and expiration dates. The weighted average strike price for the remaining 3.75 million warrants is $2.08. The qualifying order vesting dates range from December 2014 through September 2015 and the expiration dates range from December 2017 through August 2018. Any costs associated with the warrants will be recorded as a reduction of potential future revenue recorded under the arrangement. No warrants were vested and no expense was recorded as of April 30, 2014.